Genomics Services Expression Analysis offers end-to-end genomic services from whole genome to targeted gene expression and genotyping assays, along with DNA sequencing, sequence enrichment, and bioinformatics support, indicating opportunities to upsell integration of multiple platforms and data analysis packages.

Platform Expertise With established workflows around Affymetrix GeneChip and GeneTitan, Agilent Sure Select, Illumina BeadChip and iScan, PacBio sequencing, and other technologies, there is potential to position cross-platform assay development and cross-technology validation services to biotech and pharma clients.

Clinical Compliance CLIA-registered laboratory with GLP-compliant quality systems following CLSI guidelines signals reliability for contract testing, quality-sensitive customers, and potential collaboration on regulated diagnostic or companion diagnostic development projects.

Sample Versatility Capability to work with challenging specimens such as whole blood and FFPE tissues opens doors to oncology, translational research, and retrospective studies where sample quality and preservation are critical, suggesting targeted outreach to cancer and pathology-focused accounts.

Scale & Growth Current revenue in the lower single to mid-range of biotech services and a lean team size presents a clear path for scalable services, partnerships, and managed services engagements as potential account expansion for larger biotechs or CROs seeking specialized genomic workflows.